The JNK interacting protein JIP-1 and insulin like growth factor II genes are co-expressed in human embryonic tumours

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 1075-1078

  Engström, Wilhelm ^a   Rising, Anna ^a   Grip, Stefan ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

IGF II; JIP 1; Testicular tumours

Indexed keywords

JNK INTERACTING PROTEIN; PROTEIN JIP 1; SOMATOMEDIN B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; EMBRYONAL TISSUE; GENE EXPRESSION REGULATION; GERM CELL TUMOR; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, NORTHERN; CARCINOMA, EMBRYONAL; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; POLY A; RNA, NEOPLASM; TESTICULAR NEOPLASMS;

EID: 17444391705     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Engström W, Hopkins B and Schofield P: Expression of growth regulatory genes in primary human testicular neoplasms. Int J Androl 10: 79-84, 1987.
2. Schofield PN and Engström W: Insulin like growth factors in human cancer. In: The Insulin like Growth Factors - Structure and Biological Function. Schofield PN, ed. Oxford University Press, pp. 240-257, 1990.
3. Engström W, Tally M, Granerus M, Hedley EP and Schofield P: Growth factors and the control of human teratoma cell proliferation. Recent Res Cancer Res 123: 145-153, 1991.
4. Derijard B, Hibi M, Wu IH, Barrett T, Han J, Ulevitch RJ and Davis RJ: JNK 1 - a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell 76: 1025-1037, 1994.
5. Garrington TP and Johnsson GL: Organisation and regulation of mitogen activated protein kinase signalling pathways. Curr Op Cell Biol 19: 211-218, 1999.
6. Sluss HK, Han Z, Barrett T, Davis RJ and Ip T: A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Develop 10: 2745-2757, 1996.
7. Xu X, Heidenreich O, Kitajima I, McGuire K, Li Q, Su B and Nerenberg M: Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene 13: 135-142, 1996.
8. Shim J, Lee H, Park J, Kim H and Choi EJ: A non enzymatic p21 protein inhibitor of stress activated protein kinases. Nature 381: 804-807, 1996.
9. Verheij M, Bose R, Hua LX, Yao B, Jarvis W, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN: Requirement for ceramide initiated SAPK/JNK signalling in stress induced apoptosis. Nature 350: 75-78, 1996.
10. Park J, Kim T, Oh YJ, Lee KW, Han PL and Choi EJ: Activation of c-jun N-terminal kinase antagonises an anti-apoptotic action of Bcl-2. J Biol Chem 272: 16725-16728, 1997.
11. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL and Davis RJ: A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277: 693-696, 1997.
12. Whitmarsh AJ, Cavanagh C, Yasuda J and Davis RJ: A mammalian scaffold complex that selectively mediates MAP-kinase activation. Science 281: 1671-1674, 1998.
13. Verhey KJ, Meyer D, Deehan R, Blenis J, Schnapp BJ, Rapoport TA and Margolis B: Cargo of kinesin identified as JIP scaffolding proteins and associated molecules. J Cell Biol 752: 959-970, 2001.
14. Barr RK, Kendrick TS and Bogoyevitch MA: Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 277: 10987-10997, 2002.
15. Finn SG, Dickens M and Fuller SJ: c-Jun N-terminal kinase interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes. Biochem J 358: 489-495, 2001.
16. Hyldahl L, Engström W and Schofield PN: Stimulatory effects of basic fibroblast growth factor on the human embryonic cornea. Development 109: 693-703, 1990.
17. Engström W, Granerus M and Sachsenmaier W: Differential gene expresion of 3- hydroxy 3-methylglutaryl coenzyme A reductase and N-Myc during the synchronous nuclear cycle of Physarum polycephalum. Cell Biol Int Rep 16: 1133-1137, 1992.
18. Rohbe L, Larsson M, Rising A, Grip S, Burns J and Engström W: Expression of JNK interacting protein JIP-1 is down-regulated in liver from mouse embryos with a disrupted insulin like growth factor II gene. In Vivo 18: 643-648, 2004.
19. Thompson NA, Haeflinger JA, Senn A, Tawadros T, Magara F, Ledermann B, Nicod P and Waeber G: Islet-brain 1/JNK interacting protein 1 is required for early embryogenesis in mice. J Biol Chem 276: 27745-27748, 2001.
20. Damjanov I: Pathobiology of human germ cell neoplasia. Rec Res Cancer Res 123: 1-19: 1991.
21. Drescher B, Lauke H, Hartmann M, Davidoff MS and Zumkeller W: Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. Mol Pathol 50: 298-303, 1997.
22. de Chiara T, Robertson E and Efstradiatis A: A growth deficiency phenotype in heterozygous mice carrying an insulin like growth factor II gene disrupted by targetting. Nature 345: 78-80, 1990.
23. deChiara T, Robertson E and Efstradiatis A: Parental imprinting of the mouse insulin like growth factor II gene. Cell 64: 849-859, 1991.
24. Haig D and Graham CF: Genomic imprinting and the strange case of the insulin like growth factor II receptor. Cell 64: 1045-1046, 1991.
25. Ward A, Bierke P, Pettersson E and Engström W: Insulin like growth factors; growth, transgenes and imprinting. Zool Sci 11: 167-174, 1994.
26. Engström W, Shokrai A, Otte K, Granerus M, Gessbo, Bierke P, Madej A, Sjölund M and Ward A: Transcriptional regulation and biological significance of the insulin like growth factor II gene. Cell Prol 31: 1-16, 1998.
27. Dell G, Ward A, Shokrai A, Madej A and Engström W: Regulation of the IGF system by Glucocorticoids. Zool Sci 16: 377-385, 1999.